A new study by the Federal Trade Commission as well as a report issued by the House Oversight Committee have confirmed what many policymakers and health policy experts have been saying for the last few years: little-known middlemen in the healthcare sector, called pharmacy benefit managers, or PBMs, are one of the biggest drivers of…